Effects of triptolide on the expression of MHC II in microglia in kainic acid‑induced epilepsy

Sun,Zheng; Du,Meng; Lu,Yao; Zeng,Chang‑Qian

doi:10.3892/mmr.2018.8891

Effects of triptolide on the expression of MHC II in microglia in kainic acid‑induced epilepsy

Authors:
- Zheng Sun
- Meng Du
- Yao Lu
- Chang‑Qian Zeng
View Affiliations

Affiliations: Medical College, Dalian University, Dalian, Liaoning 116622, P.R. China, Neonatal Screening Center, Maternal and Child Health Care Hospital of Dalian, Dalian, Liaoning 116033, P.R. China
Published online on: April 18, 2018 https://doi.org/10.3892/mmr.2018.8891
Pages: 8357-8362

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to determine whether triptolide (T10) had any effect on major histocompatibility complex class II (MHC II) expression in kainic acid (KA)‑activated microglia, and to investigate the underlying molecular mechanism. BV‑2 microglia were pretreated with T10 prior to activation with KA. The expression level of MHC II and class II transactivator (CIITA) mRNA was determined via reverse transcription‑polymerase chain reaction. The expression of MHC II, CIITA and the phosphorylation level of c‑Jun and proto‑oncogene c‑Fos (c‑Fos) was determined by western blotting. The protein expression level of MHC II was determined by immunocytochemistry. It was observed that the mRNA and protein levels of MHC II and CIITA were increased in KA‑activated BV‑2 microglia, and that this increase was almost completely eliminated by T10. AP‑1 is a family of homodimers or heterodimers, composed of Jun family and Fos family proteins. Sequence analysis revealed an AP‑1 DNA binding site in the promoter of CIITA. The phosphorylation of c‑Jun and c‑Fos was increased in KA‑activated microglia, while T10 was able to suppress the phosphorylation of c‑Jun and c‑Fos in KA‑activated microglia. These data suggested that T10 may exert suppressive effects on MHC II expression in KA‑activated microglia, and that the mechanism may involve the regulation of AP‑1 activity.

View Figures

View References

1	Duncan JS, Sander JW, Sisodiya SM and Walker MC: Adult epilepsy. Lancet. 367:1087–1100. 2006. View Article : Google Scholar : PubMed/NCBI
2	Tegelberg S, Kopra O, Joensuu T, Cooper JD and Lehesjoki AE: Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1. J Neuropathol Exp Neurol. 71:40–53. 2012. View Article : Google Scholar : PubMed/NCBI
3	de Graaf KL, Barth S, Herrmann MM, Storch MK, Otto C, Olsson T, Melms A, Jung G, Wiesmüller KH and Weissert R: MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis. J Immunol. 173:2792–2802. 2004. View Article : Google Scholar : PubMed/NCBI
4	Casas C, Herrandograbulosa M, Manzano R, Mancuso R, Osta R and Navarro X: Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav. 3:145–158. 2013. View Article : Google Scholar : PubMed/NCBI
5	Vardjan N, Gabrijel M, Potokar M, Svajger U, Kreft M, Jeras M, de Pablo Y, Faiz M, Pekny M and Zorec R: IFN-γ-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments. J Neuroinflammation. 9:1442012. View Article : Google Scholar : PubMed/NCBI
6	Beach TG, Woodhurst WB, Macdonald DB and Jones MW: Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy. Neurosci Lett. 191:27–30. 1995. View Article : Google Scholar : PubMed/NCBI
7	Depboylu C, Stricker S, Ghobril JP, Oertel WH, Priller J and Höglinger GU: Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease. Exp Neurol. 238:183–191. 2012. View Article : Google Scholar : PubMed/NCBI
8	Wojtera M, Sobów T, Kłoszewska I, Liberski PP, Brown DR and Sikorska B: Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: Morphometric study and review of the literature. Folia Neuropathol. 50:74–84. 2012.PubMed/NCBI
9	Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis JB, Medhurst AD and Dexter DT: Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: A time course study in a 6-hydroxydopamine model of Parkinson's disease. J Neurochem. 110:966–975. 2009. View Article : Google Scholar : PubMed/NCBI
10	Nakahara H, Konishi Y, Beach TG, Yamada N, Makino S and Tooyama I: Infiltration of T lymphocytes and expression of icam-1 in the hippocampus of patients with hippocampal sclerosis. Acta Histochem Cytochem. 43:157–162. 2010. View Article : Google Scholar : PubMed/NCBI
11	Shaw JA, Perry VH and Mellanby J: MHC class II expression by microglia in tetanus toxin-induced experimental epilepsy in the rat. Neuropathol Appl Neurobiol. 20:392–398. 1994. View Article : Google Scholar : PubMed/NCBI
12	Tao X, Cush JJ, Garret M and Lipsky PE: A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol. 28:2160–2167. 2001.PubMed/NCBI
13	Du F, Liu T, Liu T, Wang Y, Wan Y and Xing J: Metabolite identification of triptolide by data-dependent accurate mass spectrometric analysis in combination with online hydrogen/deuterium exchange and multiple data-mining techniques. Rapid Commun Mass Spectrom. 25:3167–3177. 2011. View Article : Google Scholar : PubMed/NCBI
14	Gu WZ, Chen R, Brandwein S, Mcalpine J and Burres N: Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: Triptolide and tripdiolide. Int J Immunopharmacol. 17:351–356. 1995. View Article : Google Scholar : PubMed/NCBI
15	Li FQ, Lu XZ, Liang XB, Zhou HF, Xue B, Liu XY, Niu DB, Han JS and Wang XM: Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation. J Neuroimmunol. 148:24–31. 2004. View Article : Google Scholar : PubMed/NCBI
16	Jiao J, Xue B, Zhang L, Gong Y, Li K, Wang H, Jing L, Xie J and Wang X: Triptolide inhibits amyloid-beta1-42-induced TNF-alpha and IL-1beta production in cultured rat microglia. J Neuroimmunol. 205:32–36. 2008. View Article : Google Scholar : PubMed/NCBI
17	Lu Y, Sun Z, Zeng CQ and Gao S: Effect of triptolide on the expression of MHC molecules on microglia of kainite-induced rat brain. J Liaoning Univ. 14:112–114. 2012.(In Chinese).
18	Kreutzberg GW: Microglia: A sensor for pathological events in the CNS. Trends Neurosci. 19:312–318. 1996. View Article : Google Scholar : PubMed/NCBI
19	Ponomarev ED, Novikova M, Maresz K, Shriver LP and Dittel BN: Development of a culture system that supports adult microglial cell proliferation and maintenance in the resting state. J Immunol Methods. 300:32–46. 2005. View Article : Google Scholar : PubMed/NCBI
20	Li H, Liu ZH, Dai CS, Liu D and Li LS: Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells. Acta Pharmacol Sin. 23:775–781. 2002.PubMed/NCBI
21	Boss JM and Jensen PE: Transcriptional regulation of the MHC class II antigen presentation pathway. Curr Opin Immunol. 15:105–111. 2003. View Article : Google Scholar : PubMed/NCBI
22	Gongora C, Hose S, O'Brien TP and Sinha D: Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940. Immunol Lett. 91:11–16. 2004. View Article : Google Scholar : PubMed/NCBI
23	Chang CH, Guerder S, Hong SC, van Ewijk W and Flavell RA: Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:167–178. 1996. View Article : Google Scholar : PubMed/NCBI
24	Nikodemova M, Watters JJ, Jackson SJ, Yang SK and Duncan ID: Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. J Biol Chem. 282:15208–15216. 2007. View Article : Google Scholar : PubMed/NCBI
25	Kim SH, Smith CJ and Van Eldik LJ: Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging. 25:431–439. 2004. View Article : Google Scholar : PubMed/NCBI
26	Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R and Alcaide-Loridan C: Pathologic expression of MHC class II is driven by mitogen-activated protein kinases. Eur J Immunol. 37:788–797. 2007. View Article : Google Scholar : PubMed/NCBI